Legato Capital Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1442641 San Francisco, CA

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$387,105

-$200,478 QoQ

Shares Held

3,064

-27.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#1,512

of 2,266 holders

Holding Since

Sep 2020

6 quarters on record

Healthcare · as of Jun 30, 2026

Legato Capital Management LLC holds $15,619,590 across 5 Drug Manufacturers - General names. GILD ranks #5 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	74,128	$4,271,255
2	AMGN	Amgen Inc	11,630	$4,211,455
3	PFE	Pfizer Inc	145,221	$3,496,921
4	LLY	ELI LILLY & Co	2,712	$3,252,854
5	GILD	Gilead Sciences, Inc. This page	3,064	$387,105

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$387,105	3,064	-27.3%	Shares	Other	2026-08-06
2026-03-31	$587,583	4,216	-39.9%	Shares	Other	2026-05-14
2025-12-31	$861,143	7,016	-73.5%	Shares	Other	2026-02-06
2021-03-31	$1,712,695	26,500	0.0%	Shares	Other	2021-04-21
2020-12-31	$1,543,890	26,500	0.0%	Shares	Other	2021-01-21
2020-09-30	$1,674,535	26,500	—	Shares	Other	2020-10-13
No filing history on record for this holder in this stock.